150 related articles for article (PubMed ID: 3123643)
1. Effect of PGE2 on sulfonylurea induced insulin release.
Villar A; Ivorra MD; Anselmi E
J Physiol (Paris); 1987; 82(1):12-7. PubMed ID: 3123643
[TBL] [Abstract][Full Text] [Related]
2. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
Katsumata K; Katsumata Y
Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
[No Abstract] [Full Text] [Related]
3. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
4. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
Hausmann L; Schumann G; Kaffarnik H
Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
[TBL] [Abstract][Full Text] [Related]
5. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
Gotfredsen CF
Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of PGE1 on the liberation of insulin induced by glibenclamide].
Villar A; D'Ocón MP; Anselmi E
Rev Esp Fisiol; 1985 Dec; 41(4):451-5. PubMed ID: 3938043
[TBL] [Abstract][Full Text] [Related]
8. [Comparative use of gliquidone and tolbutamide administered intravenously].
Zilker T; Lüders L; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
[No Abstract] [Full Text] [Related]
9. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
Joost HG; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
[TBL] [Abstract][Full Text] [Related]
10. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
11. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
Rothenbuchner G; Raptis S; Pfeiffer EF
Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
[No Abstract] [Full Text] [Related]
12. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
Bickel M; Geisen K; Schleyerbach R
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
14. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
15. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F
J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic and acute treatment with sulfonylureas on plasma insulin and glucose levels in the rat.
Codina J; Lasuncion MA; Herrera E
Diabete Metab; 1978 Mar; 4(1):47-52. PubMed ID: 97105
[No Abstract] [Full Text] [Related]
17. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
[TBL] [Abstract][Full Text] [Related]
18. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
19. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
20. [Insulin secretion following combined administration of glucose and different sulfonylurea compounds in equipotential doses in metabolically healthy persons].
Happ J; Beyer J; Jungmann E; Scherer U; Haupt E; Schöffling K
Verh Dtsch Ges Inn Med; 1973; 79():1213-6. PubMed ID: 4208215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
